Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
Phase 1b Dose Expansion Study of NXC-201 for the Treatment of Patients with Relapsed or Refractory AL Amyloidosis
Clinical Trial Grant
Duke Scholars
Principal Investigator
Cristiana A. Costa
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
Nexcella, Inc.
Start Date
September 11, 2025
End Date
August 17, 2030
Awarded By
Nexcella, Inc.
Start Date
September 11, 2025
End Date
August 17, 2030
